Liquidity Events

Carlyle sells Piramal Pharma shares worth Rs.38-Cr

Stock Exchange Data  

Global investment firm Carlyle has sold shares worth INR 37.87 crore in publicly-listed Piramal Pharma. Post the sale, Carlyle holds a 17.83% stake in the company.

From the Venture Intelligence PE-VC Deal Database: In Jun-20, Piramal Pharma had attracted USD 490 M from Carlyle.

Want to receive such news items in your inbox? Click Here to sign up for a trial.

2021 © TSJ Media Pvt Ltd. All rights reserved.